Superworth

Artiva Biotherapeutics EPS ARTV

Diluted earnings per share by quarter and over the last twelve months, from 2023.

Last 12 months, to Jun 30, 2026
−$3.31
Latest quarter, Q2 FY26
−$0.63
Fiscal year 2025
−$3.43

Artiva Biotherapeutics' earnings per share was −$3.31 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.63.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$3.43n/a
FY2024−$40.82n/a
FY2023−$48.36n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.63n/a−$3.31
Q1 FY26−$0.95n/a−$3.55
Q4 FY25−$0.85n/a−$3.43
Q3 FY25−$0.88n/a−$3.24
Q2 FY25−$0.87n/a−$3.28
Q1 FY25−$0.83n/a−$24.41
Q4 FY24−$0.66n/a−$40.82
Q3 FY24−$0.92−157%−$54.99
Q2 FY24−$22.00n/a−$52.45
Q1 FY24−$17.24n/a−$44.54
Q4 FY23−$14.83n/a−$48.36
Q3 FY23$1.62n/an/a

Against its peers

Companies in Healthcare nearest Artiva Biotherapeutics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
ARTVArtiva Biotherapeutics−$3.31
PLXProtalix BioTherapeutics$0.23+283% a year
NATRNatures Sunshine Products$1.01+36% a year
ELMDElectromed$1.31+56% a year
UTMDUtah Medical Products$3.28−12% a year
PDEXPro DEX$3.63+8% a year
INFUInfuSystem$0.41+78% a year
CYHCommunity Health Systems$0.26−89% a year
EMBCEmbecta$1.47+3% a year
VMDViemed Healthcare$0.36+6% a year
CRMDCorMedix$2.13+184% a year
Peer median$1.16

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Artiva Biotherapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.